Checkpoint Therapeutics, Inc. - Common Stock (CKPT)

Historical Holders from Q4 2022 to Q1 2025

Symbol
CKPT on Nasdaq
CUSIP
162828206
Type / Class
Equity / Common Stock
Shares outstanding
61.4M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
11.1M
Holdings value
$35.4M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
68
Number of buys
43
Number of sells
-15
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Checkpoint Therapeutics, Inc. - Common Stock (CKPT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Fortress Biotech, Inc. 11.2% -17.7% $28M $74.7K 6.92M +0.27% Fortress Biotech, Inc. Mar 9, 2025
Beryl Capital Management LLC 9.9% $24.5M 6.07M Beryl Capital Management LLC Mar 10, 2025
ARMISTICE CAPITAL, LLC 9.99% $21.1M 5.22M Armistice Capital, LLC Dec 31, 2024
GLAZER CAPITAL, LLC 6.41% $12.5M 3.09M Glazer Capital, LLC Mar 10, 2025

Institutional Holders of Checkpoint Therapeutics, Inc. - Common Stock (CKPT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 535K $2.16M -$426K $4.04 6
2024 Q4 11.1M $35.4M +$10.8M $3.20 68
2024 Q3 7.68M $17.2M +$4.11M $2.24 45
2024 Q2 5.87M $12.6M +$795K $2.15 45
2024 Q1 5.38M $11M +$1.27M $2.05 38
2023 Q4 4.88M $11.2M +$2.46M $2.29 41
2023 Q3 3.87M $6.57M +$2.16M $1.70 37
2023 Q2 2.57M $6.36M +$3.15M $2.47 32
2023 Q1 1.39M $3.14M -$3.67M $2.25 31
2022 Q4 1.78M $9.12M +$9.11M $5.11 34